This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07934/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07934/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07934/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07934/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07934/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07934
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n4:DB07934 n9:DB07934
dcterms:title
[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE
adms:identifier
n6:I11 n10:395603 n11:448953 n12:99444405 n14:DB07934
n7:IUPAC-Name
n8:271B4DB7-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B4DBD-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B4DBC-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B4DB9-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B4DBA-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B4DBB-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B4DB5-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B4DB6-363D-11E5-9242-09173F13E4C5 n8:271B4DB3-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B4DB4-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B4DC3-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B4DC4-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B4DBE-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B4DBF-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B4DC1-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B4DC0-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B4DC2-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B4DC9-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B4DCB-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B4DCC-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B4DC8-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B4DC7-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B4DCA-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B4DB8-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B4DC5-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B4DC6-363D-11E5-9242-09173F13E4C5